Member Info for Spikeyj

arix oversubscribed, including some bought up by woody, but nothing dynamic on the IPO'd sp.

a roaring start. one for patient folks.

another small nibble.

a few of my shorter term trade stock this pm. still long on investment position. happy to wait for a bigger dip to add more re s/t trade.

if i see 50s again, i add.

dow not a game for me, but good luck hot. seems irrationally high, but animal spirits abound. strange times we live in.

(cashed out now, for now.)

"We have been notified that Globo plc was dissolved on 28 January 2017. This follows the announcement on 3 November 2015 that the Company was placed into Administration and the Shares were delisted from the Alternative Investment Market (AIM)."

nice progress, eh.

yes, cashed in a few circa 512, but remaining long and looking to add back in again at a lower price if i see it, pretty please. market as a whole having a good day, but surely time for a setback? (preferably not a north korea nukes USA kind of setback though, i don't want to buy 'em back quite that low.)

it's a beauty.

sold a couple, but still long.

? would you settle for some RDSB if there is no RDSD available for you?

cheers guys, your thoughts appreciated. have a good sunday.

i'm not that into the black arts of TA, nothing against 'em on liquid major shares, just too lazy to put time in to learn. may i ask, from a TA perspective, where would you currently see the major resistance level(s) between here and 550? (promise i won't hold you to them!)

hot, been chanting oooom hard as i can, still not quite enough it seems. ... so maybe next week / next month / next year / manyana. atb.

mi divi

like it.

Aviva edged higher after announcing the sale of its 50% stake in life insurance joint venture Antarius to Sogecap, a subsidiary of French bank Société Générale, for £425m (€500m).

i note there's an IPO shortly of an early stage bioscience investor company that woodford is supporting, might be interesting to see how market receives that relative to wpct. (apparently it targets even earlier stages) arix biosciences.